Mary Mediatrix Medical Center | Center for Research and Development

Research site
JP LAUREL HIGHWAY LIPA CITY, Lipa City, Batangas, Philippines
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site


9 of 19
Status: Active
Trial type: Interventional
Funder type: Industry

A Phase III Study Evaluating the Efficacy and Safety of Crovalimab Versus Eculizumab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Not Previously Treated With Complement Inhibitors. (COMMODORE 2)

A study designed to evaluate the non-inferiority of crovalimab compared with eculizumab in participants with PNH who have not been previously treated...

Active, not recruiting
Paroxysmal Nocturnal Hemoglobinuria
Drug: Eculizumab
Drug: Crovalimab

This study is comparing 200 milligrams (mg) of filgotinib a day with a placebo to see if filgotinib helps to treat Axial Spondyloarthritis (axSpA) an...

Axial Spondyloarthritis
Drug: Placebo
Drug: Filgotinib

The purpose of this study is to assess the efficacy and safety of zetomipzomib (30 mg or 60 mg) compared with placebo in achieving renal response aft...

Lupus Nephritis
Drug: placebo
Drug: zetomipzomib

The primary objectives of the study are to evaluate the efficacy of BIIB059 (litifilimab) compared with placebo in reducing skin disease activity mea...

Subacute Cutaneous Lupus Erythematosus
Chronic Cutaneous Lupus Erythematosus
Drug: BIIB059 (litifilimab)
Drug: Placebo

This study will evaluate the efficacy and safety of astegolimab compared with placebo in participants with chronic obstructive pulmonary disease (COP...

Chronic Obstructive Pulmonary Disease (COPD)
Drug: Placebo
Drug: Astegolimab

The primary objective of this study is to evaluate the long-term safety and tolerability of litifilimab in participants with active systemic lupus er...

Systemic Lupus Erythematosus (SLE)
Drug: Litifilimab-matching placebo
Drug: Litifilimab

The primary objective of this study is to demonstrate efficacy of litifilimab (BIIB059) compared with placebo in participants with active systemic lu...

Lupus Erythematosus, Systemic
Drug: Litifilimab
Drug: Placebo

A Global, Multi-center, Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Study to Evaluate the Efficacy, Safety, and Immunogenicity o...

Active, not recruiting
COVID-19 Pandemic
Biological: Recombinant SARS-CoV-2 fusion protein vaccine (V-01)
Other: Blank Preparation of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01)

The purpose of this Proof of Concept (PoC) and Dose-finding (DF) basket study is to evaluate the efficacy and safety of orally administered Enpatoran...

Systemic Lupus Erythematosus
Drug: Enpatoran low dose
Drug: Placebo

Trial conditions

Arthritis (6 trials)
Rheumatoid Arthritis (5 trials)
Systemic Lupus Erythemat... (5 trials)
Hemoglobinuria (2 trials)
Lupus Nephritis (2 trials)
Nephritis (2 trials)
Paroxysmal Hemoglobinuria (2 trials)
Axial Spondyloarthritis (1 trial)
COVID-19 (1 trial)
Chronic Obstructive Pulm... (1 trial)

And 8 more

Clinical trials

Find clinical trialsTrials by location


© Copyright 2024 Veeva Systems